middle.news
How Genetic Signatures’ 63% Revenue Surge Signals a New Growth Era
10:37pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Genetic Signatures’ 63% Revenue Surge Signals a New Growth Era
10:37pm on Friday 29th of August, 2025 AEST
Key Points
63% revenue growth to $15.9 million driven by Australian respiratory sales
Underlying loss reduced by 28% to $12.7 million despite $7 million impairment
First US commercial contract secured post FDA clearance
Strategic partnerships with Tecan Group and Repado to develop automated platform
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE